Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288

Predicting new molecular targets for known drugs

Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667

Drug target identification using side-effect similarity

Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248

Drug repurposing: progress, challenges and recommendations

Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718

Genomic responses in mouse models poorly mimic human inflammatory diseases

Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005

Machine learning for integrating data in biology and medicine: principles, practice, and opportunities

Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675

Systematic integration of biomedical knowledge prioritizes drugs for repurposing

Himmelstein, D. S., Lizee, A., Hessler, C., Brueggeman, L., Chen, S. L., Hadley, D., Green, A., Khankhanian, P., & Baranzini, S. E. (2017) · eLife · doi:10.7554/elife.26726 · Cited by 666

Network-based in silico drug efficacy screening

Guney, E., Menche, J., Vidal, M., & Barábasi, A.-L. (2016) · Nature Communications · doi:10.1038/ncomms10331 · Cited by 625

A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions

Jarada, T. N., Rokne, J. G., & Alhajj, R. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00450-7 · Cited by 384

Applications of Connectivity Map in drug discovery and development

Qu, X. A., & Rajpal, D. K. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.07.017 · Cited by 235

Modules, networks and systems medicine for understanding disease and aiding diagnosis

Gustafsson, M., Nestor, C. E., Zhang, H., Barabási, A.-L., Baranzini, S., Brunak, S., Chung, K. F., Federoff, H. J., Gavin, A.-C., Meehan, R. R., et al. (2014) · Genome Medicine · doi:10.1186/s13073-014-0082-6 · Cited by 194

Towards understanding brain-gut-microbiome connections in Alzheimer’s disease

Xu, R., & Wang, Q. (2016) · BMC Systems Biology · doi:10.1186/s12918-016-0307-y · Cited by 175

Design of efficient computational workflows for in silico drug repurposing

Vanhaelen, Q., Mamoshina, P., Aliper, A. M., Artemov, A., Lezhnina, K., Ozerov, I., Labat, I., & Zhavoronkov, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.019 · Cited by 150

A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK

Campbell, J. D., McDonough, J. E., Zeskind, J. E., Hackett, T. L., Pechkovsky, D. V., Brandsma, C.-A., Suzuki, M., Gosselink, J. V., Liu, G., Alekseyev, Y. O., et al. (2012) · Genome Medicine · doi:10.1186/gm367 · Cited by 128

Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer’s disease

Taubes, A., Nova, P., Zalocusky, K. A., Kosti, I., Bicak, M., Zilberter, M. Y., Hao, Y., Yoon, S. Y., Oskotsky, T., Pineda, S., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00122-7 · Cited by 118

qSVA framework for RNA quality correction in differential expression analysis

Jaffe, A. E., Tao, R., Norris, A. L., Kealhofer, M., Nellore, A., Shin, J. H., Kim, D., Jia, Y., Hyde, T. M., Kleinman, J. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617384114 · Cited by 114

Drug–target interaction predication via multi-channel graph neural networks

Li, Y., Qiao, G., Wang, K., & Wang, G. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab346 · Cited by 112

Linking Phenotypes and Modes of Action Through High-Content Screen Fingerprints

Reisen, F., Sauty de Chalon, A., Pfeifer, M., Zhang, X., Gabriel, D., & Selzer, P. (2015) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2015.656 · Cited by 76

Enabling Precision Cardiology Through Multiscale Biology and Systems Medicine

Johnson, K. W., Shameer, K., Glicksberg, B. S., Readhead, B., Sengupta, P. P., Björkegren, J. L. M., Kovacic, J. C., & Dudley, J. T. (2017) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2016.11.010 · Cited by 83

Alzheimer’s disease large-scale gene expression portrait identifies exercise as the top theoretical treatment

Hill, M. A., & Gammie, S. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-22179-z · Cited by 56

OCTAD: an open workspace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features

Zeng, B., Glicksberg, B. S., Newbury, P., Chekalin, E., Xing, J., Liu, K., Wen, A., Chow, C., & Chen, B. (2021) · Nature Protocols · doi:10.1038/s41596-020-00430-z · Cited by 48

Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing

Chan, J., Wang, X., Turner, J. A., Baldwin, N. E., & Gu, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz006 · Cited by 50

Targeting SALL4 by entinostat in lung cancer

Yong, K. J., Li, A., Ou, W.-B., Hong, C. K. Y., Zhao, W., Wang, F., Tatetsu, H., Yan, B., Qi, L., Fletcher, J. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12251 · Cited by 41

Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders

Schadt, E. E., Buchanan, S., Brennand, K. J., & Merchant, K. M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00252 · Cited by 39

The opportunities of mining historical and collective data in drug discovery

Wassermann, A. M., Lounkine, E., Davies, J. W., Glick, M., & Camargo, L. M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.004 · Cited by 34

Can cancer researchers accurately judge whether preclinical reports will reproduce?

Benjamin, D., Mandel, D. R., & Kimmelman, J. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2002212 · Cited by 32

Integration of genetically regulated gene expression and pharmacological library provides therapeutic drug candidates

Konuma, T., Ogawa, K., & Okada, Y. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab049 · Cited by 22

Using Chemical-Induced Gene Expression in Cultured Human Cells to Predict Chemical Toxicity

Liu, R., Yu, X., & Wallqvist, A. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00287 · Cited by 8

Prediction and identification of synergistic compound combinations against pancreatic cancer cells

KalantarMotamedi, Y., Choi, R. J., Koh, S.-B., Bramhall, J. L., Fan, T.-P., & Bender, A. (2021) · iScience · doi:10.1016/j.isci.2021.103080 · Cited by 8

A gene expression signature of emphysematous lung destruction and its reversal by the tripeptide GHK

Campbell, J. D., McDonough, J. E., Zeskind, J. E., Hackett, T. L., Pechkovsky, D. V., Brandsma, C.-A., Suzuki, M., Gosselink, J. V., Liu, G., Alekseyev, Y. O., et al. (2012) · Genome Medicine · doi:10.1186/gm368 · Cited by 5